LianBio - ADR

NASDAQ:LIAN   3:59:52 PM EDT
3.00
+0.33 (+12.36%)
Earnings Announcements

LianBio Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/30/2022 22:36 GMT
LianBio - ADR (LIAN) - Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Cash, Cash Equivalents, Marketable Securities, Restricted Cash at Dec 31, 2021 Totaled $403.2 Million.
Projects Its Cash Position is Sufficient to Fund Current Operations Through 2023.
Qtrly Net Loss per Share Attributable to Ordinary Shareholders, Basic and Diluted $0.28.
Q4 Earnings per Share View $-0.72 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.